共 114 条
[1]
Nyirenda MJ(2009)Hyperkalaemia BMJ 339 b4114-51
[2]
Tang JI(2004)Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 543-4
[3]
Padfield PL(2003)Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines J Am Coll Cardiol 41 211-11
[4]
Seckl JR(2008)Hyperkalaemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit Circulation 118 1609-92
[5]
Juurlink DN(2004)Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system N Engl J Med 351 585-62
[6]
Mamdani MM(2009)The frequency of hyperkalemia and its significance in chronic kidney disease Arch Intern Med 169 1156-50
[7]
Lee DS(2008)Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Circulation 118 1643-21
[8]
Kopp A(2011)Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 11-13
[9]
Austin PC(2012)Predictors of hyperkalemia and death in patients with cardiac and renal disease Am J Cardiol 109 1510-303
[10]
Laupacis A(2004)How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail 10 297-14